Goldman Sachs’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Goldman Sachs’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-54,236	Closed	-$282K	–	7296
2016 Q4	$282K	Buy	54,236 +20,527	+61%	+$96.5K	﹤0.01%	5534
2016 Q3	$157K	Sell	33,709 -387	-1%	-$1.81K	﹤0.01%	5979
2016 Q2	$134K	Buy	34,096 +4,521	+15%	+$16.9K	﹤0.01%	5978
2016 Q1	$92K	Buy	29,575 +14,228	+93%	+$47.7K	﹤0.01%	6111
2015 Q4	$70K	Sell	15,347 -157,172	-91%	-$745K	﹤0.01%	6385
2015 Q3	$813K	Sell	172,519 -40,428	-19%	-$261K	﹤0.01%	4677
2015 Q2	$1.52M	Buy	212,947 +195,902	+1,149%	+$1.47M	﹤0.01%	4126
2015 Q1	$144K	Sell	17,045 -458	-3%	-$3.9K	﹤0.01%	6240
2014 Q4	$163K	Sell	17,503 -10,582	-38%	-$92K	﹤0.01%	6307
2014 Q3	$234K	Buy	28,085 +16,716	+147%	+$155K	﹤0.01%	6014
2014 Q2	$131K	Buy	+11,369	New	+$117K	﹤0.01%	6449

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Goldman Sachs's DSCI Position: Q1 2017 in Review

Goldman Sachs sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 54,236 shares — an estimated $282K sold.

Goldman Sachs first reported a position in DSCI in Q2 2014 and held it in 11 quarters. The position peaked at $1.52M in Q2 2015. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

Goldman Sachs reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
Goldman Sachs sold 54,236 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $282K.
Goldman Sachs first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2014 and held it in 11 quarters.
Goldman Sachs's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.52M in Q2 2015.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.